ArticleOrphanet journal of rare diseases2025
The global burden of motor neuron disease: a systematic and additional analysis of global burden disease study 2021.
Article in Orphanet journal of rare diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Diverging trends in motor neuron disease burden in China: an ageing-driven increase despite declining age-standardised rates - a GBD 2021 analysis.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026Article
- Immune imbalance between T helper 1, T helper 17 and regulatory T cells fuels amyotrophic lateral sclerosis pathogenesis: disease trajectory, diagnosis and therapeutic implications.Journal of neuroinflammation · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
backgroundThe last 30 years witnessed significant changes in motor neuron disease (MND) epidemiology. Our study aims to explore the trends and inequality of MND, and predict future changes to 2046.
methodsWe used Global Burden of Disease (GBD) 2021 data and methodologies (including trends, decomposition, inequality, frontier, and prediction) to describe the disease burden of MND of incidence, prevalence, deaths, and disability-adjusted life-years (DALYs).
resultsThe case number of incidence, prevalence, deaths and DALYs illustrated an upward trend, however, the age-standardized rate (ASR) for these metrics remained stable. There is substantial variability in MND burden across regions and countries, with higher ASR observed in high sociodemographic index (SDI) regions, particularly the United States, Finland, and the United Kingdom. Gender and age differences also contribute to the disease burden, with males and older populations exhibiting higher incidence rates. The age-period-cohort analysis revealed distinct temporal trends of DALYs across age, period, and birth cohort. Decomposition analysis revealed population aging and growth are critical drivers of the increasing burden. Additionally, the cross-country inequality analysis indicates widening disparities in MND burden, particularly in high SDI regions, from 1990 to 2021. Forecasts for 2046 suggest that while the number of deaths and DALYs may decrease, the incidence and prevalence of MND are expected to continue rising. The frontier analysis further reveals significant differences in performance across countries, with certain high-SDI countries like Sweden and the United Kingdom underperform, indicating that socioeconomic advancements may not always translate into lower disease burden.
conclusionsThe findings from this study underscore the need for more targeted interventions, better diagnostic practices, and international collaboration to address the growing global burden of MND. These insights offer a significant contribution to understanding the trends and regional disparities associated with MND, aiding in the development of global health strategies and public health policies to mitigate this burden.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.